Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q1- Text added to 2017 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
New words:
Abbreviated, acute, Alkem, Amneal, Aurobindo, BENEPALITM, California, cerebral, Cipla, CIRARA, CIRARATM, Circuit, core, counted, counterparty, creation, Delaware, dementia, depicted, disproportionately, DMT, edema, enable, expedite, fatal, feasibility, FLIXABITM, forfeiture, framework, fulminant, FZE, Glenmark, half, hemispheric, Hetero, Impax, IMRALDI, IMRALDITM, infantile, infarction, ischemic, leaner, LHI, liver, Lupin, maximizing, Milan, Ministry, modification, morbidity, mortality, MSN, Mylan, neuroimmunology, neuromuscular, neuropsychiatry, OCREVUSTM, ophthalmology, Par, Pharmathen, preceding, predecessor, Prinston, prioritized, prove, provisionally, Pvt, ransomware, rapidly, reallocate, resilience, SA, Sandoz, Sawai, Shipla, simpler, Slayback, split, Stason, stroke, Sun, surrender, swelling, temporary, Teva, top, Torren, TWI, unclear, unissued, unsuitable, unused, USA, Virginia, Welfare, West, withheld
Valuein 2017 Q1 filing- Value in 2017 Q2 filing
Original filings
Filing view